Ipravent 20 mcg Inhaler 200 mdi
₹136.08*
MRP ₹151.2
10% off
₹128.2*
MRP ₹151.2
15% CB
₹23 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Ipravent 20 mcg Inhaler 200 mdi belongs to a class of medications called ‘anticholinergics’ used to treat asthma and chronic obstructive pulmonary disease (COPD). Asthma is a condition in which airways narrow and swollen, resulting in difficulty breathing, coughing, and wheezing (whistling sound). COPD is a chronic (long-term) condition occurring due to a group of lung diseases such as emphysema (a condition in which air sacs of lungs are damaged) and chronic bronchitis (inflammation of tubes (bronchi) that carry air to and from in lungs).
Ipravent 20 mcg Inhaler 200 mdi contains ‘Ipratropium bromide’ which is an anticholinergic. It is used to treat symptoms associated with chronic lung conditions and reduce the risk of frequent asthma attacks. It acts as a bronchodilator and works by dilating the muscles in the airway. It also reduces mucus (phlegm) production. This effect helps to improve lung function and reduce breathing difficulty. It is a short-acting drug.
Ipravent 20 mcg Inhaler 200 mdi is available only for inhalation. Use this medicine as prescribed by your doctor. The common side-effects of Ipravent 20 mcg Inhaler 200 mdi are headache, dizziness, epistaxis (nosebleed), nausea, nasal dryness, nasal irritation, stomach upset, and cough, and throat irritation after inhalation. Most of these side-effects resolve themselves without requiring medical attention. However, if the side-effects persist or worsen, seek medical help immediately.
Do not take Ipravent 20 mcg Inhaler 200 mdi if you are allergic to ‘ipratropium bromide’ or any other ingredients present in it. Before taking Ipravent 20 mcg Inhaler 200 mdi, inform your doctor if you have a history of glaucoma (an eye condition), urinary retention and an enlarged prostate gland. Inform your doctor if you are using any prescription, non-prescription or nutritional supplements, Also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Ipravent 20 mcg Inhaler 200 mdi contains ‘ipratropium bromide’ which is an ‘anticholinergic’ drug. It is a widely used bronchodilator. It can effectively reduce symptoms of asthma, chronic obstructive pulmonary disease(COPD) and other lung conditions. It can also decrease the risk of recurrent asthma episodes. It helps to improve lung function. It relaxes the muscles along the airway passage easing the breathing difficulty. It reduces phlegm production improving cough symptoms. Besides, it has a quick onset of action.
Do not take Ipravent 20 mcg Inhaler 200 mdi if you are allergic to ‘ipratropium bromide’ or any ingredients present in it. This medicine should be used with caution in patients with glaucoma (increased inside pressure of the eye) and urinary retention. The inhalation should be used carefully. Ensure the medicine does not reach the eye as it may result in eye problems such as mydriasis (dilation of the pupil), increased pressure inside the eye, and angle-closure glaucoma (a condition caused by blocked drainage canals in the eye), eye pain, and visual halos. If you develop paradoxical bronchospasm (sudden narrowing of bronchi muscles leading to obstructed breathing), you should discontinue treatment immediately and consult a doctor. This medicine should be used with caution in pregnant and breastfeeding women.
Drug-drug interactions: Ipravent 20 mcg Inhaler 200 mdi may interact with other anticholinergics used to treat COPD (tiotropium), irritable bowel syndrome (mebeverine), urinary incontinence (oxybutynin and solifenacin), or cough (e.g. dextromethorphan). It may also interact with other drugs that treat lung diseases (salbutamol, theophylline, and aminophylline).
Drug-food interactions: No interactions found.
Drug-disease interactions: Ipravent 20 mcg Inhaler 200 mdi should be used with caution in patients with glaucoma, enlarged prostate gland, cystic fibrosis (an inherited disorder that damages lungs and gut), and urinary retention (difficulty passing urine).
Asthma: It is a chronic (long-term) condition in which the airways become swollen and narrowed due to inflammation. It also results in increased production of mucus (thick fluid secreted by respiratory tissues) in the airways. Symptoms include breathing difficulty, coughing, and wheezing (a whistling sound).
Chronic obstructive pulmonary disease (COPD): It is a chronic inflammation that occurs due to a group of conditions such as emphysema, chronic bronchitis and refractory or recurrent asthma. Emphysema is a condition in which alveoli (air sacs) get damaged leading to shortness of breath. Chronic bronchitis is a condition in which the bronchus (passage of airway that conducts air) becomes inflamed leading to increased sputum production.
Country of origin
Manufacturer/Marketer address
Alcohol
Caution
Alcohol may worsen the condition, so do not take alcohol while using Ipravent 20 mcg Inhaler 200 mdi.
Pregnancy
Caution
Ipravent 20 mcg Inhaler 200 mdi is a Category B medicine and may not harm the unborn babies. It should be used in pregnant women if clinically needed.
Breast Feeding
Caution
Ipravent 20 mcg Inhaler 200 mdi should be used with caution in breastfeeding mothers.
Driving
Caution
Ipravent 20 mcg Inhaler 200 mdi may cause dizziness and affect your ability to drive. So, do not drive or operate heavy machinery after using Ipravent 20 mcg Inhaler 200 mdi.
Liver
Caution
Ipravent 20 mcg Inhaler 200 mdi should be used with caution in patients with liver diseases.
Kidney
Caution
Ipravent 20 mcg Inhaler 200 mdi should be used with caution in patients with kidney diseases. Dose adjustments may be necessary.
Children
Caution
Ipravent 20 mcg Inhaler 200 mdi can be used in children if clinically needed.